188.42 0.00 (0.00%)
After hours: 4:15PM EST
|Bid||188.03 x 900|
|Ask||188.32 x 1200|
|Day's Range||187.90 - 194.91|
|52 Week Range||148.89 - 259.72|
|Beta (5Y Monthly)||0.90|
|PE Ratio (TTM)||55.63|
|Earnings Date||Feb 25, 2020 - Mar 01, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||201.50|
Vivek Jain has been the CEO of ICU Medical, Inc. (NASDAQ:ICUI) since 2014. This analysis aims first to contrast CEO...
SAN CLEMENTE, Calif., Jan. 07, 2020 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Our research shows that most of the stocks that smart money likes historically generate strong […]
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]
ICU Medical (ICUI) delivered earnings and revenue surprises of 1.85% and 6.10%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
SAN CLEMENTE, Calif., Nov. 11, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
Pursuit Vascular, which makes devices to thwart infection in kidney-disease patients, has agreed to be bought by ICU Medical Inc.
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN CLEMENTE, Calif., Nov. 4, 2019 /PRNewswire/ -- ICU Medical, Inc. (ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, announced today that it has entered into a definitive agreement to acquire Pursuit Vascular, Inc. for $75M with an additional earnout payment potentially due in 2021. Pursuit Vascular is a privately-held medical device company with a primary focus on innovative catheter disinfecting products and technologies to reduce costly bloodstream infections and lower healthcare costs. Pursuit Vascular's primary product is the ClearGuard® HD cap, which is used for the maintenance of hemodialysis catheters.
LAKE FOREST, Ill. , Oct. 30, 2019 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq: ICUI) is voluntarily recalling one single lot of Lactated Ringer's Injection, USP, and one single lot of 0.9% Sodium Chloride ...
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
SAN CLEMENTE, Calif., Oct. 22, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Jeff Ubben, George Soros and Carl Icahn think. Those hedge fund operators make billions of […]
SAN CLEMENTE, Calif. , Oct. 7, 2019 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq: ICUI) announced a voluntary recall on 29 July 2019 of certain lots of Plum and Sapphire Microbore Infusion Sets with inline ...
SAN CLEMENTE, Calif., Sept. 09, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
ICU Medical, Inc. (ICUI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...